Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis.
作者信息
Verroken Alexia, Scohy Anaïs, Gérard Ludovic, Wittebole Xavier, Collienne Christine, Laterre Pierre-François
机构信息
Department of Microbiology, Cliniques Universitaires Saint-Luc - Université Catholique de Louvain, Avenue Hippocrate 10, Brussels, Belgium.
Intensive Care Department, Cliniques Universitaires Saint-Luc - Université Catholique de Louvain, Avenue Hippocrate 10, Brussels, Belgium.
出版信息
Crit Care. 2020 Jul 9;24(1):410. doi: 10.1186/s13054-020-03135-7.
Abstract
摘要
相似文献
1
Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis.新冠重症患者的合并感染与抗生素管理：一项前瞻性队列分析
Crit Care. 2020 Jul 9;24(1):410. doi: 10.1186/s13054-020-03135-7.
2
Response to "Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis".对《新冠肺炎危重症患者的合并感染与抗生素管理：一项前瞻性队列分析》的回应
Crit Care. 2020 Sep 29;24(1):591. doi: 10.1186/s13054-020-03308-4.
3
Bacterial and fungal colonization of the respiratory tract in COVID-19 patients should not be neglected.新冠病毒肺炎患者呼吸道的细菌和真菌定植不容忽视。
Am J Infect Control. 2020 Sep;48(9):1130-1131. doi: 10.1016/j.ajic.2020.06.185. Epub 2020 Jun 25.
4
Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients.感染患者中SARS-CoV-2与多种常见呼吸道病原体的合并感染。
Sci China Life Sci. 2020 Apr;63(4):606-609. doi: 10.1007/s11427-020-1668-5. Epub 2020 Mar 5.
5
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
6
Bacterial coinfections in COVID-19: an underestimated adversary.COVID-19 中的细菌合并感染：被低估的对手。
Ann Ist Super Sanita. 2020 Jul-Sep;56(3):359-364. doi: 10.4415/ANN_20_03_14.
7
Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia - Something to Be Concerned About?新冠病毒肺炎中糖皮质激素诱导的细菌性心内膜炎——值得关注吗？
Circ J. 2020 Sep 25;84(10):1887. doi: 10.1253/circj.CJ-20-0462. Epub 2020 Aug 7.
8
Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study.羟氯喹在新冠肺炎危重症患者中的药代动力学：一项观察性队列研究。
Intensive Care Med. 2020 Sep;46(9):1772-1773. doi: 10.1007/s00134-020-06142-y. Epub 2020 Jun 8.
9
Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).新冠肺炎危重症患者的静脉血栓栓塞症。
JAMA Netw Open. 2020 May 1;3(5):e2010478. doi: 10.1001/jamanetworkopen.2020.10478.
10
Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan.分析新冠病毒和非新冠病毒（包括流感病毒），以确定日本强化预防措施的影响。
J Clin Virol. 2020 Aug;129:104543. doi: 10.1016/j.jcv.2020.104543. Epub 2020 Jul 7.
引用本文的文献
1
Rapid diagnostics to enhance therapy selection for the treatment of bacterial infections.用于改善细菌感染治疗中治疗方案选择的快速诊断方法。
Curr Pharmacol Rep. 2023 Aug;9(4):198-216. doi: 10.1007/s40495-023-00323-1. Epub 2023 Jun 29.
2
Prevalence, Risk Factors, and Outcome of Carbapenem-resistant Infections in a Community Hospital in Madinah, Saudi Arabia.沙特阿拉伯麦地那一家社区医院耐碳青霉烯类感染的患病率、危险因素及结局
Saudi J Med Med Sci. 2024 Oct-Dec;12(4):306-313. doi: 10.4103/sjmms.sjmms_582_23. Epub 2024 Oct 12.
3
Bacterial Community- and Hospital-Acquired Pneumonia in Patients with Critical COVID-19-A Prospective Monocentric Cohort Study.重症新型冠状病毒肺炎患者的细菌群落与医院获得性肺炎——一项前瞻性单中心队列研究
Antibiotics (Basel). 2024 Feb 16;13(2):192. doi: 10.3390/antibiotics13020192.
4
Low Rate of Bacterial Coinfections and Antibiotic Overprescribing During COVID-19 Pandemic: A Retrospective Study from Oman.COVID-19大流行期间细菌合并感染率低及抗生素过度处方情况：阿曼的一项回顾性研究
Oman Med J. 2023 Jul 31;38(4):e525. doi: 10.5001/omj.2023.83. eCollection 2023 Jul.
5
Coinfection and superinfection in ICU critically ill patients with severe COVID-19 pneumonia and influenza pneumonia: are the pictures different?COVID-19 重症肺炎和流感肺炎 ICU 危重症患者的合并感染和再感染：两者的表现是否不同？
Front Public Health. 2023 Aug 29;11:1195048. doi: 10.3389/fpubh.2023.1195048. eCollection 2023.
6
Implementation of a Rapid Multiplex Polymerase Chain Reaction Pneumonia Panel and Subsequent Antibiotic De-escalation.快速多重聚合酶链反应肺炎检测板的应用及后续抗生素降阶梯治疗
Open Forum Infect Dis. 2023 Jul 17;10(8):ofad382. doi: 10.1093/ofid/ofad382. eCollection 2023 Aug.
7
Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021).2019 年 7 月至 2021 年 10 月期间，美国多中心队列评估：住院患者中 SARS-CoV-2 状态和抗生素耐药菌与经验性治疗不足的关系。
BMC Infect Dis. 2023 Jul 24;23(1):490. doi: 10.1186/s12879-023-08453-z.
8
Bacterial Superinfection and Antibiotic Management in Patients with COVID-19 Admitted to Intensive Care Medicine in Central Iran: A Follow-Up Study.伊朗中部重症监护医学科收治的新冠肺炎患者的细菌二重感染及抗生素管理：一项随访研究
Adv Biomed Res. 2023 Feb 25;12:43. doi: 10.4103/abr.abr_82_22. eCollection 2023.
9
Impact of the COVID-19 Outbreak on the Antibiotic Use Patterns among a Rural Community Population in Eastern China.新冠疫情对中国东部农村社区人群抗生素使用模式的影响。
Antibiotics (Basel). 2022 Nov 3;11(11):1544. doi: 10.3390/antibiotics11111544.
10
A Cephalosporin-Tripodalamine Conjugate Inhibits Metallo-β-Lactamase with High Efficacy and Low Toxicity.一种头孢菌素-三足形胺缀合物高效低毒抑制金属β-内酰胺酶。
Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0035222. doi: 10.1128/aac.00352-22. Epub 2022 Sep 12.
本文引用的文献
1
Evaluation of the BioFire FilmArray Pneumonia Panel for Detection of Viral and Bacterial Pathogens in Lower Respiratory Tract Specimens in the Setting of a Tertiary Care Academic Medical Center.在三级医疗学术医学中心环境下，评估BioFire FilmArray肺炎检测板对下呼吸道标本中病毒和细菌病原体的检测能力。
J Clin Microbiol. 2020 Jun 24;58(7). doi: 10.1128/JCM.00343-20.
2
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
3
Management of Critically Ill Adults With COVID-19.新型冠状病毒肺炎危重症成人患者的管理
JAMA. 2020 May 12;323(18):1839-1841. doi: 10.1001/jama.2020.4914.
4
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
5
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件